Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

HIBERIA

Diseases
Viruses
Country
France
Registration Year
2024
Manufacturer
KWS
No active offers.
Views
17
Reviews
0
Producer
KWS
Description HIBERIA
The rapeseed hybrid HIBERIA is one of the most popular and widely used in Europe due to its high resistance to turnip yellow vein virus (TuYV) and excellent winter hardiness. This mid-early hybrid is characterized by rapid autumn growth and strong branching, which contributes to high yields with potential up to 70.6 c/ha. HIBERIA has good oil content and genetic resistance to pod cracking, making it a reliable choice for various agronomic conditions.

The hybrid demonstrates stable performance in different climatic and soil conditions, including sandy loam, clay loam, and clay soils. It adapts well to various cultivation technologies with different resource availability and effectively utilizes mineral nitrogen. Recommended sowing dates vary from early (August 1-10) to late (August 20-30), with seeding rates ranging from 400,000 to 600,000 seeds/ha depending on sowing time. The use of morphoregulators is recommended for optimal plant development, especially when sowing is done early or at optimal times.

HIBERIA is suitable for cultivation in all zones and requires optimal planting density. Thanks to its high compensatory capacity and the possibility of delaying harvest by up to 10 days, this hybrid provides flexibility in agronomic practices. Its plasticity and stability make HIBERIA an excellent choice for farmers seeking high-quality rapeseed yields under various climatic conditions.
Specifications HIBERIA
Diseases
Viruses
Yellowing and leaf curl viruses
Hybrid Type
Simple Linear
Yield Potential
60-70 ц/га
Number of plants per hectare
400 thousand pcs/ha
500 thousand pcs/ha
600 thousand pcs/ha
Plant: Branching
High
Country
France
Registration Year
2024
Catalog
Varieties
Technical Crops
Manufacturer
KWS
Where to buy HIBERIA
Loading...
Reviews HIBERIA
0comments
Sort by:Popular first
No comments yet.